RSS
Press Releases
Trusted reliable news sources from around the web. We offer special news reports, topic news videos, and related content stories. Truly a birds eye view on news.
- Details
- Written by Globe NewsWire Press Releases
- Category: Globe NewsWire News Distribution Service
Basel, May 31, 2026 – Novartis today announced results showing consistent radiographic progression-free survival (rPFS) improvement across key subgroups with Pluvicto™ (lutetium Lu 177 vipivotide tetraxetan) plus standard of care (SoC; androgen receptor pathway inhibitor [ARPI] + androgen deprivation therapy [ADT]) compared to SoC alone in PSMA-positive metastatic hormone-sensitive prostate cancer (mHSPC). These PSMAddition data…
- Details
- Written by Globe NewsWire Press Releases
- Category: Globe NewsWire News Distribution Service
SACRAMENTO, Calif, May 30, 2026 (GLOBE NEWSWIRE) -- Solana Unchained today disclosed the comprehensive operational structure of its upcoming decentralized platform, which unifies artificial intelligence features with three specialized infrastructure protocols. Scheduled to open its initial public allocation phase on May 30, 2026, the ecosystem establishes a functional framework where every internal network service requires…
- Details
- Written by Globe NewsWire Press Releases
- Category: Globe NewsWire News Distribution Service
איסלאמאבאד, May 31, 2026 (GLOBE NEWSWIRE) -- משרד ההסברה והשידור הפקיסטני (MoIB) אחראי על קידום וניהול הנרטיב הרשמי סביב ביקורו של ראש ממשלת פקיסטן שהבז שריף בסין, בציון 75 שנה לכינון היחסים הדיפלומטיים.
- Details
- Written by Globe NewsWire Press Releases
- Category: Globe NewsWire News Distribution Service
NEW YORK, May 30, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Upstart Holdings, Inc. (NASDAQ: UPST) between May 14, 2025 and November 4, 2025, inclusive (the “Class Period”), of the important June 8, 2026 lead plaintiff deadline.
- Details
- Written by Globe NewsWire Press Releases
- Category: Globe NewsWire News Distribution Service
ORION CORPORATION PRESS RELEASE 30 MAY 2026 at 21:30 EEST Orion Pharma announces first results from Phase 1/2 TEADES trial with TEAD inhibitor ODM-212 in patients with advanced solid tumours
- Details
- Written by Globe NewsWire Press Releases
- Category: Globe NewsWire News Distribution Service
– Post hoc analysis from pivotal Launch-HTN trial shows statistically significant and clinically meaningful reductions in blood pressure in participants with chronic kidney disease – – In participants with chronic kidney disease and baseline albuminuria, lorundrostat significantly reduced urine albumin-to-creatinine ratio –
Globe NewsWire News Distribution Service Article Count: 1444
Media Partner Network Article Count: 4
Send2Press NewsWire Distribution Service Article Count: 502
Related Product Search/Búsqueda de productos relacionados
